Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Swart

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Rheumatology (Oxford, England)|July 4, 2024
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity ScoreRoberta Naddei, Francesca Ridella, Francesca Bovis, et al.
MDM Policy & Practice|October 2, 2025
Development and Qualitative Evaluation of a Decision Support Tool for Withdrawal of Biologic Therapy in Nonsystemic Juvenile Idiopathic ArthritisJanine A van Til, Michelle M A Kip, Robert Marinescu-Muster, et al.
Arthritis Care & Research|May 3, 2021
Costs of Hospital-Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care SystemMichelle M A Kip, Sytze de Roock, Inge van den Berg, et al.
Pediatric Rheumatology Online Journal|November 15, 2022
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort studyJoeri W van Straalen, Sytze de Roock, Gabriella Giancane, et al.
The Patient|March 24, 2022
Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis: A Formative Qualitative StudyGillian R Currie, Tram Pham, Marinka Twilt, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 27, 2020
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare systemMichelle M A Kip, Sytze de Roock, Gillian Currie, et al.
Archives of Disease in Childhood|June 9, 2019
Fatigue in childhood chronic diseaseMerel M Nap-van der Vlist, Geertje W Dalmeijer, Martha A Grootenhuis, et al.
Rheumatology and Therapy|July 18, 2021
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort StudyLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
BMJ Paediatrics Open|June 3, 2021
Daily life participation in childhood chronic disease: a qualitative study on the child's and parent's perspectiveMerel M Nap-van der Vlist, Emma E Berkelbach van der Sprenkel, Linde N Nijhof, et al.
Pediatric Rheumatology Online Journal|July 11, 2023
Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?Janine A van Til, Michelle M A Kip, Ellen J H Schatorjé, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|July 4, 2024
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity ScoreRoberta Naddei, Francesca Ridella, Francesca Bovis, et al.
MDM Policy & Practice|October 2, 2025
Development and Qualitative Evaluation of a Decision Support Tool for Withdrawal of Biologic Therapy in Nonsystemic Juvenile Idiopathic ArthritisJanine A van Til, Michelle M A Kip, Robert Marinescu-Muster, et al.
Arthritis Care & Research|May 3, 2021
Costs of Hospital-Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care SystemMichelle M A Kip, Sytze de Roock, Inge van den Berg, et al.
Pediatric Rheumatology Online Journal|November 15, 2022
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort studyJoeri W van Straalen, Sytze de Roock, Gabriella Giancane, et al.
The Patient|March 24, 2022
Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis: A Formative Qualitative StudyGillian R Currie, Tram Pham, Marinka Twilt, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 27, 2020
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare systemMichelle M A Kip, Sytze de Roock, Gillian Currie, et al.
Archives of Disease in Childhood|June 9, 2019
Fatigue in childhood chronic diseaseMerel M Nap-van der Vlist, Geertje W Dalmeijer, Martha A Grootenhuis, et al.
Rheumatology and Therapy|July 18, 2021
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort StudyLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
BMJ Paediatrics Open|June 3, 2021
Daily life participation in childhood chronic disease: a qualitative study on the child's and parent's perspectiveMerel M Nap-van der Vlist, Emma E Berkelbach van der Sprenkel, Linde N Nijhof, et al.
Pediatric Rheumatology Online Journal|July 11, 2023
Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?Janine A van Til, Michelle M A Kip, Ellen J H Schatorjé, et al.
Pageof 12